chr21:36160098:> Detail (hg19) (RUNX1)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr21:36,160,098-36,421,641 |
hg38 | chr21:34,787,801-35,049,344 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
acute myeloid leukemia | B |
![]() |
![]() |
Poor Outcome | Somatic | 3 | 27137476 | Detail | |
acute myeloid leukemia | Cytarabine | B |
![]() |
![]() |
Resistance | Somatic | 4 | 21343560 | Detail |
acute myeloid leukemia | B |
![]() |
![]() |
Poor Outcome | Somatic | 4 | 21343560 | Detail | |
acute myeloid leukemia | B |
![]() |
![]() |
Poor Outcome | Somatic | 4 | 21343560 | Detail | |
acute lymphoblastic leukemia | B |
![]() |
![]() |
Poor Outcome | Somatic | 3 | 23341344 | Detail | |
acute myeloid leukemia | B |
![]() |
![]() |
Poor Outcome | Somatic | 4 | 22753902 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
<0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
0.005 | Congenital chromosomal disease | Amplification of c-MYC, MLL and RUNX1 genes by means of fluorescence in situ hyb... | BeFree | 26214902 | Detail |
0.005 | Congenital chromosomal disease | A recurrent chromosomal abnormality in acute myeloid leukemia is the reciprocal ... | BeFree | 26333776 | Detail |
0.002 | ulcerative colitis | NA | GAD | Detail | |
<0.001 | colorectal carcinoma | NA | BeFree | Detail | |
<0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
0.002 | Crohn Disease | NA | GAD | Detail | |
0.003 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
<0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
0.133 | Down syndrome | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Dwarfism | NA | BeFree | Detail | |
0.080 | endometriosis | NA | RGD | Detail | |
<0.001 | Ependymoma | NA | BeFree | Detail | |
0.003 | Esophageal Neoplasms | LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a pre... | BeFree,GAD | 25486427 | Detail |
0.001 | Exanthema | NA | BeFree | Detail | |
0.004 | Fanconi anemia | NA | BeFree,LHGDN | Detail | |
0.120 | glioblastoma | NA | CTD_human | Detail | |
<0.001 | Glioma | Taken together, our present study indicated that miR-18a increased the permeabil... | BeFree | 25452107 | Detail |
<0.001 | congenital heart defects | NA | BeFree | Detail | |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
<0.001 | Hepatosplenomegaly | NA | BeFree | Detail | |
<0.001 | Congenital hypoplasia | NA | BeFree | Detail | |
0.115 | leukemia | Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predispo... | BeFree,GAD,LHGDN | 25066130 | Detail |
0.115 | leukemia | Altogether, RUNX1 dosage could explain the differential phenotype according to R... | BeFree,GAD,LHGDN | 25490895 | Detail |
0.115 | leukemia | C/EBPα expression is suppressed as a result of common leukemia-associated geneti... | BeFree,GAD,LHGDN | 25760953 | Detail |
0.115 | leukemia | Further investigation into the clinical and biological significance of elevated ... | BeFree,GAD,LHGDN | 26111797 | Detail |
0.115 | leukemia | RUNX1 and CBFB are among the most frequently mutated genes in human leukemias. | BeFree,GAD,LHGDN | 26165235 | Detail |
0.115 | leukemia | Thus, Wnt/β-catenin signaling induces transcription and translocation of RUNX1 a... | BeFree,GAD,LHGDN | 26333776 | Detail |
0.003 | lymphoid leukemia | Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Child... | BeFree | 26185316 | Detail |
0.045 | Acute lymphocytic leukemia | Copy number genome alterations are associated with treatment response and outcom... | BeFree | 24241490 | Detail |
0.045 | Acute lymphocytic leukemia | We have addressed the issue in the context of TEL-AML1-associated acute lymphobl... | BeFree | 24909160 | Detail |
0.045 | Acute lymphocytic leukemia | Through a novel approach combining gene expression and interactome data analysis... | BeFree | 25273558 | Detail |
0.045 | Acute lymphocytic leukemia | Patients with B-other ALL had more relapses (CIR 50%, LFS 41%) than T-ALL and th... | BeFree | 25312094 | Detail |
0.045 | Acute lymphocytic leukemia | We reasoned that shared clonal rearrangements of IG or TCR genes by concordant A... | BeFree | 25388957 | Detail |
0.045 | Acute lymphocytic leukemia | Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Child... | BeFree | 26185316 | Detail |
0.028 | Leukemia, Lymphocytic, Acute, L1 | We analyzed cells from peripheral blood and CD34-/CD34+ cells from bone marrow o... | BeFree | 25244981 | Detail |
0.002 | Acute Megakaryocytic Leukemias | NA | BeFree | Detail | |
<0.001 | acute monocytic leukemia | NA | BeFree | Detail | |
0.261 | Leukemia, Myelocytic, Acute | AML1-ETO triggers epigenetic activation of early growth response gene l, inducin... | BeFree,CTD_human,GAD,LHGDN | 24314118 | Detail |
0.261 | Leukemia, Myelocytic, Acute | To investigate the physiological function of RUNX1 in human hematopoiesis and pa... | BeFree,CTD_human,GAD,LHGDN | 24732596 | Detail |
0.261 | Leukemia, Myelocytic, Acute | Mutations of RUNX1 have been reported to be associated with familial platelet di... | BeFree,CTD_human,GAD,LHGDN | 24853048 | Detail |
0.261 | Leukemia, Myelocytic, Acute | The RUNX1/ETO (RE) fusion protein, which originates from the t(8;21) chromosomal... | BeFree,CTD_human,GAD,LHGDN | 24897507 | Detail |
0.261 | Leukemia, Myelocytic, Acute | RUNX1 translocations and amplifications have been implicated in acute myeloblast... | BeFree,CTD_human,GAD,LHGDN | 24912843 | Detail |
0.261 | Leukemia, Myelocytic, Acute | Here we identify somatic mutations in additional sex combs-like 2 (ASXL2) in 22.... | BeFree,CTD_human,GAD,LHGDN | 24973361 | Detail |
0.261 | Leukemia, Myelocytic, Acute | ASXL1 mutation, particularly in the context of a coexisting RUNX1 mutation, cons... | BeFree,CTD_human,GAD,LHGDN | 25596267 | Detail |
0.261 | Leukemia, Myelocytic, Acute | To elucidate the role of epigenetics in RUNX inactivation, we evaluated promoter... | BeFree,CTD_human,GAD,LHGDN | 25612675 | Detail |
0.261 | Leukemia, Myelocytic, Acute | In acute myeloid leukaemia (AML), the presence of t(8;21)(q22;q22) and inv(16)(p... | BeFree,CTD_human,GAD,LHGDN | 25635758 | Detail |
0.261 | Leukemia, Myelocytic, Acute | In this study, we present a novel Tet2-dependent leukemia mouse model that close... | BeFree,CTD_human,GAD,LHGDN | 25886910 | Detail |
0.261 | Leukemia, Myelocytic, Acute | Because of the pressing need for new therapies in the treatment of acute myleoid... | BeFree,CTD_human,GAD,LHGDN | 25928846 | Detail |
0.261 | Leukemia, Myelocytic, Acute | These findings clearly indicate that the RUNX1 mutation is robustly associated w... | BeFree,CTD_human,GAD,LHGDN | 26021490 | Detail |
0.261 | Leukemia, Myelocytic, Acute | We identified chromosomal deletions within the WASP gene in two patients with Wi... | BeFree,CTD_human,GAD,LHGDN | 26175287 | Detail |
0.261 | Leukemia, Myelocytic, Acute | Amplification of c-MYC, MLL and RUNX1 genes by means of fluorescence in situ hyb... | BeFree,CTD_human,GAD,LHGDN | 26214902 | Detail |
0.261 | Leukemia, Myelocytic, Acute | A recurrent chromosomal abnormality in acute myeloid leukemia is the reciprocal ... | BeFree,CTD_human,GAD,LHGDN | 26333776 | Detail |
0.261 | Leukemia, Myelocytic, Acute | In accordance with our observation that increased expression of miR-126 is assoc... | BeFree,CTD_human,GAD,LHGDN | 26361793 | Detail |
0.015 | myeloid leukemia | Acute multilineage (B/myeloid) leukemia with RUNX1 duplication/amplification and... | BeFree,LHGDN | 24912843 | Detail |
0.130 | Myeloid Leukemia, Chronic | NA | BeFree,LHGDN,ORPHANET | Detail | |
<0.001 | Leukemia, Myeloid, Chronic-Phase | NA | BeFree | Detail | |
<0.001 | acute myelomonocytic leukemia | NA | BeFree | Detail | |
0.006 | Leukemia, Myelomonocytic, Chronic | NA | BeFree,GAD | Detail | |
0.122 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree,CTD_human | Detail | |
0.003 | acute promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | Leukoencephalopathy, Progressive Multifocal | NA | BeFree | Detail | |
0.002 | liver cirrhosis | NA | GAD | Detail | |
<0.001 | Lung diseases | NA | BeFree | Detail | |
<0.001 | Lupus Erythematosus, Systemic | NA | BeFree | Detail | |
<0.001 | Lymphohistiocytosis, Hemophagocytic | NA | BeFree | Detail | |
<0.001 | lymphoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
<0.001 | melanoma | NA | BeFree | Detail | |
0.001 | Monosomy | NA | BeFree | Detail | |
0.003 | multiple myeloma | NA | LHGDN | Detail | |
0.004 | Myelodysplasia | Mutations of RUNX1 have been reported to be associated with familial platelet di... | BeFree | 24853048 | Detail |
<0.001 | myelofibrosis | NA | BeFree | Detail | |
0.002 | Myeloproliferative disease | Here, we show that Runx1;Runx3 double-knockout (DKO) mice exhibited lethal pheno... | BeFree | 25066130 | Detail |
0.002 | Myeloproliferative disease | In mouse models, class I mutations such as the Bcr-Abl fusion kinase induce MPN ... | BeFree | 25504228 | Detail |
<0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
<0.001 | nephroblastoma | NA | BeFree | Detail | |
<0.001 | neurofibromatosis 1 | NA | BeFree | Detail | |
<0.001 | ovarian carcinoma | NA | BeFree | Detail | |
0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
0.004 | pancytopenia | Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predispo... | BeFree,LHGDN | 25066130 | Detail |
<0.001 | Pituitary Diseases | NA | BeFree | Detail | |
<0.001 | Pituitary Neoplasms | NA | BeFree | Detail | |
<0.001 | platelet storage pool deficiency | NA | BeFree | Detail | |
<0.001 | polycythemia | NA | BeFree | Detail | |
<0.001 | polycythemia vera | NA | BeFree | Detail | |
<0.001 | Precancerous Conditions | NA | BeFree | Detail | |
0.013 | Preleukemia | Somatic mutation of RUNX1 is implicated in various hematological malignancies, i... | BeFree,GAD | 24732596 | Detail |
0.013 | Preleukemia | Mutations of RUNX1 have been reported to be associated with familial platelet di... | BeFree,GAD | 24853048 | Detail |
0.013 | Preleukemia | Currently, Clinical Laboratory Improvement Amendments-approved testing exists fo... | BeFree,GAD | 25311743 | Detail |
0.120 | Prostatic Neoplasms | NA | CTD_human | Detail | |
0.003 | psoriasis | NA | BeFree,GAD | Detail | |
0.003 | schizophrenia | NA | BeFree,GAD | Detail | |
<0.001 | Scoliosis, unspecified | NA | BeFree | Detail | |
<0.001 | Skin Neoplasms | NA | BeFree | Detail | |
0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
0.008 | thrombocytopenia | NA | LHGDN | Detail | |
0.002 | Tobacco use disorder | NA | GAD | Detail | |
0.002 | Trisomy | NA | BeFree | Detail | |
<0.001 | Wiskott-Aldrich syndrome | We identified chromosomal deletions within the WASP gene in two patients with Wi... | BeFree | 26175287 | Detail |
0.012 | acute leukemia | Familial platelet disorder (FPD)/AML is an autosomal dominant disorder caused by... | BeFree | 24732596 | Detail |
<0.001 | Atrophic condition of skin | NA | BeFree | Detail | |
0.003 | Myocardial Ischemia | NA | BeFree,LHGDN | Detail | |
0.120 | Muscle Weakness | NA | CTD_human | Detail | |
<0.001 | esophageal carcinoma | LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a pre... | BeFree | 25486427 | Detail |
<0.001 | Patau syndrome | NA | BeFree | Detail | |
<0.001 | Granulocytic Sarcoma | NA | BeFree | Detail | |
<0.001 | Tumor Progression | NA | BeFree | Detail | |
<0.001 | Carcinoma, Endometrioid | NA | BeFree | Detail | |
0.001 | Adult Acute Myeloblastic Leukemia | NA | BeFree | Detail | |
0.002 | pediatric acute myeloblastic leukemia | NA | BeFree | Detail | |
<0.001 | Congenital defects | NA | BeFree | Detail | |
<0.001 | Mastocytosis, Systemic | NA | BeFree | Detail | |
<0.001 | Mental condensation | NA | BeFree | Detail | |
<0.001 | Chronic intestinal pseudo-obstruction | Some patients with CIPO carry mutations in RAD21 that disrupt the ability of its... | BeFree | 25575569 | Detail |
0.012 | Neoplasm, Residual | We asked whether minimal residual disease (MRD) determined by RUNX1/RUNX1T1 tran... | BeFree | 25082877 | Detail |
<0.001 | Hantavirus Infections | NA | BeFree | Detail | |
<0.001 | Childhood asthma | NA | BeFree | Detail | |
0.002 | Miller Dieker syndrome | NA | BeFree | Detail | |
<0.001 | Shwachman syndrome | NA | BeFree | Detail | |
<0.001 | recurrent childhood acute lymphoblastic leukemia | NA | BeFree | Detail | |
0.002 | Malignant Childhood Neoplasm | NA | BeFree | Detail | |
0.002 | B-cell childhood acute lymphoblastic leukemia | RUNX1 copy numbers seem to be proportional to the age of B-ALL onset and the fre... | BeFree | 26185316 | Detail |
0.121 | Squamous cell carcinoma of esophagus | Moreover, lincRNA-uc002yug.2 promoted a combination of RUNX1 and alternative spl... | BeFree,GWASCAT | 25486427 | Detail |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
0.001 | Solid tumour | Recent studies also highlight the importance of RUNX1 in solid tumors both as a ... | BeFree | 25263451 | Detail |
<0.001 | Acute Undifferentiated Leukemia | In accordance with our observation that increased expression of miR-126 is assoc... | BeFree | 26361793 | Detail |
0.002 | secondary acute myeloid leukemia | The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transfor... | BeFree | 25252869 | Detail |
<0.001 | secondary myelodysplastic syndromes | NA | BeFree | Detail | |
<0.001 | interstitial cystitis | NA | BeFree | Detail | |
<0.001 | Triploidy syndrome | NA | BeFree | Detail | |
<0.001 | Congenital neutropenia | NA | BeFree | Detail | |
<0.001 | Disseminated Malignant Neoplasm | NA | BeFree | Detail | |
<0.001 | Common acute lymphoblastic leukemia | NA | BeFree | Detail | |
0.124 | juvenile myelomonocytic leukemia | NA | BeFree,CTD_human,LHGDN | Detail | |
<0.001 | Ischemic cardiomyopathy | NA | BeFree | Detail | |
0.003 | Malignant neoplasm of prostate | These results indicated the significance of RUNX1 for androgen-dependency and th... | BeFree,GAD | 25537508 | Detail |
0.001 | Hematopoietic Neoplasms | Disruption of RUNX1 activity has been implicated in the development of hematopoi... | BeFree | 25263451 | Detail |
0.013 | Hematologic Neoplasms | Somatic mutation of RUNX1 is implicated in various hematological malignancies, i... | BeFree,LHGDN | 24732596 | Detail |
<0.001 | Developmental delay (disorder) | NA | BeFree | Detail | |
<0.001 | Chromosome 8, trisomy | The aim of our study was 1) to define if the amplification of c-MYC, MLL and RUN... | BeFree | 26214902 | Detail |
<0.001 | Acute monoblastic leukemia | NA | BeFree | Detail | |
0.002 | endometrial carcinoma | NA | BeFree | Detail | |
0.001 | Acute myeloid leukemia, minimal differentiation | NA | BeFree | Detail | |
0.120 | Malignant neoplasm of esophagus | LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a pre... | BeFree,GWASCAT | 25486427 | Detail |
<0.001 | Congenital scoliosis | NA | BeFree | Detail | |
0.003 | Carcinogenesis | Finally, we discuss how aberrant PTMs of RUNX1 might contribute to tumorigenesis... | BeFree | 25263451 | Detail |
0.030 | Leukemogenesis | FPD-iPSCs will be a useful tool to investigate mutant RUNX1-mediated molecular p... | BeFree | 24732596 | Detail |
0.030 | Leukemogenesis | RUNX1 and RUNX3 are frequently associated with leukemias, yet the basis for thei... | BeFree | 25066130 | Detail |
0.030 | Leukemogenesis | Our data on increased DSB levels in the BCR-ABL/TEL-AML1 patient's cells support... | BeFree | 25244981 | Detail |
0.030 | Leukemogenesis | AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transact... | BeFree | 25727291 | Detail |
0.030 | Leukemogenesis | We show in this study that both overexpression and knockout of microRNA (miR)-12... | BeFree | 26361793 | Detail |
<0.001 | Lymphoid neoplasm | Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilin... | BeFree | 25873510 | Detail |
<0.001 | monocytic leukemia | NA | BeFree | Detail | |
0.124 | juvenile myelomonocytic leukemia | Mutations in TET2, RUNX1 and JAK2(V617F) are involved in myelodysplastic and/or ... | BeFree | 20955399 | Detail |
0.001 | Primary myelofibrosis | AML1 mRNA expression was elevated in patients with PV, essential thrombocythemia... | BeFree | 20339092 | Detail |
<0.001 | prostate carcinoma | These results indicated the significance of RUNX1 for androgen-dependency and th... | BeFree | 25537508 | Detail |
0.002 | hepatopulmonary syndrome | NA | GAD | Detail | |
<0.001 | Epithelial ovarian cancer | MiR-302b functions as a tumor suppressor in EOC by targeting RUNX1 and modulatin... | BeFree | 25562167 | Detail |
<0.001 | Friend leukemia | NA | BeFree | Detail | |
0.001 | breast carcinoma | NA | BeFree | Detail | |
0.261 | Leukemia, Myelocytic, Acute | Among five patients diagnosed with MDS/MPN-U, three patients harboured RUNX1 (AM... | BeFree | 22571758 | Detail |
<0.001 | polycythemia vera | AML1 mRNA expression was elevated in patients with PV, essential thrombocythemia... | BeFree | 20339092 | Detail |
<0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
<0.001 | stomach carcinoma | NA | BeFree | Detail | |
<0.001 | Acquired scoliosis | NA | BeFree | Detail | |
<0.001 | Hypereosinophilia | Acute multilineage (B/myeloid) leukemia with RUNX1 duplication/amplification and... | BeFree | 24912843 | Detail |
0.002 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Jacobsen Distal 11q Deletion Syndrome | NA | BeFree | Detail | |
0.001 | Spots on skin | NA | BeFree | Detail | |
<0.001 | Leukemia secondary | NA | BeFree | Detail | |
0.003 | ovarian neoplasm | NA | LHGDN | Detail | |
<0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
0.007 | Precursor B-cell lymphoblastic leukemia | Further investigation into the clinical and biological significance of elevated ... | BeFree | 26111797 | Detail |
<0.001 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | NA | BeFree | Detail | |
<0.001 | Acute myeloid leukemia with multilineage dysplasia | NA | BeFree | Detail | |
<0.001 | Therapy-related acute myeloid leukemia and myelodysplastic syndrome | NA | BeFree | Detail | |
0.002 | Chronic myeloproliferative disorder | Here, we show that Runx1;Runx3 double-knockout (DKO) mice exhibited lethal pheno... | BeFree | 25066130 | Detail |
0.002 | Chronic myeloproliferative disorder | In mouse models, class I mutations such as the Bcr-Abl fusion kinase induce MPN ... | BeFree | 25504228 | Detail |
0.002 | Therapy-related myelodysplastic syndrome | NA | BeFree | Detail | |
<0.001 | Secondary polycythemia | NA | BeFree | Detail | |
<0.001 | M5b Acute differentiated monocytic leukemia | NA | BeFree | Detail | |
<0.001 | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | We report here a multicentre retrospective study of 157 patients treated with AZ... | BeFree | 26113240 | Detail |
0.002 | childhood leukemia | NA | BeFree | Detail | |
0.001 | Treatment related acute myeloid leukaemia | NA | BeFree | Detail | |
<0.001 | Epithelioma | NA | BeFree | Detail | |
<0.001 | Undifferentiated leukemia | In accordance with our observation that increased expression of miR-126 is assoc... | BeFree | 26361793 | Detail |
<0.001 | Mammary Neoplasms | NA | BeFree | Detail | |
<0.001 | Cancer Cell Growth | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
<0.001 | colorectal cancer | NA | BeFree | Detail | |
<0.001 | Acute myeloid leukemia, inv(16)(p13q22) | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma, Endometrioid | NA | BeFree | Detail | |
<0.001 | THROMBOCYTOPENIA 1 (disorder) | We identified chromosomal deletions within the WASP gene in two patients with Wi... | BeFree | 26175287 | Detail |
0.005 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
0.001 | ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1 | NA | BeFree | Detail | |
<0.001 | severe congenital neutropenia | NA | BeFree | Detail | |
<0.001 | DOWN SYNDROME CRITICAL REGION | NA | BeFree | Detail | |
<0.001 | THROMBOCYTOPENIA 2 (disorder) | We identified chromosomal deletions within the WASP gene in two patients with Wi... | BeFree | 26175287 | Detail |
0.002 | Acute Myeloid Leukemia (AML-M2) | NA | BeFree | Detail | |
<0.001 | uterine corpus cancer | NA | BeFree | Detail | |
0.005 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree,LHGDN | Detail | |
0.197 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Copy number genome alterations are associated with treatment response and outcom... | BeFree,CTD_human,GAD,LHGDN | 24241490 | Detail |
0.197 | Precursor Cell Lymphoblastic Leukemia Lymphoma | We have addressed the issue in the context of TEL-AML1-associated acute lymphobl... | BeFree,CTD_human,GAD,LHGDN | 24909160 | Detail |
0.197 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Through a novel approach combining gene expression and interactome data analysis... | BeFree,CTD_human,GAD,LHGDN | 25273558 | Detail |
0.197 | Precursor Cell Lymphoblastic Leukemia Lymphoma | We reasoned that shared clonal rearrangements of IG or TCR genes by concordant A... | BeFree,CTD_human,GAD,LHGDN | 25388957 | Detail |
0.197 | Precursor Cell Lymphoblastic Leukemia Lymphoma | Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Child... | BeFree,CTD_human,GAD,LHGDN | 26185316 | Detail |
<0.001 | Hyperdiploid B Acute Lymphoblastic Leukemia | NA | BeFree | Detail | |
0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
<0.001 | Treatment related leukaemia | NA | BeFree | Detail | |
<0.001 | Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement | NA | BeFree | Detail | |
0.002 | myeloid neoplasm | Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from... | BeFree | 26021490 | Detail |
<0.001 | Refractory anemia, without ringed sideroblasts, without excess blasts | NA | BeFree | Detail | |
0.035 | myelodysplastic syndrome | Somatic mutation of RUNX1 is implicated in various hematological malignancies, i... | BeFree,GAD,LHGDN | 24732596 | Detail |
0.035 | myelodysplastic syndrome | Currently, Clinical Laboratory Improvement Amendments-approved testing exists fo... | BeFree,GAD,LHGDN | 25311743 | Detail |
<0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
0.003 | intellectual disability | NA | LHGDN | Detail | |
0.120 | Leukemia, acute lymphoblastic, susceptibility to, 3 | NA | ORPHANET | Detail | |
<0.001 | core binding factor acute myeloid leukemia | The novelty of this study is dual.On the one hand, miRNAs (e.g. miR-17) can mimi... | BeFree | 25612891 | Detail |
<0.001 | Cytogenetically normal acute myeloid leukemia | NA | BeFree | Detail | |
<0.001 | Congenital Abnormality | NA | BeFree | Detail | |
0.001 | Primary myelofibrosis | The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transfor... | BeFree | 25252869 | Detail |
0.045 | Acute lymphocytic leukemia | The rs10828317 association was shown to be specifically associated with hyperdip... | BeFree | 23996088 | Detail |
0.197 | Precursor Cell Lymphoblastic Leukemia Lymphoma | The rs10828317 association was shown to be specifically associated with hyperdip... | BeFree | 23996088 | Detail |
<0.001 | anemia | NA | BeFree | Detail | |
<0.001 | aplastic anemia | NA | BeFree | Detail | |
<0.001 | Refractory anemias | NA | BeFree | Detail | |
0.001 | Refractory anaemia with excess blasts | NA | BeFree | Detail | |
0.136 | rheumatoid arthritis | Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid ... | BeFree,CTD_human,GAD,LHGDN | 24972750 | Detail |
0.003 | asthma | NA | BeFree,GAD | Detail | |
<0.001 | Astrocytoma | NA | BeFree | Detail | |
0.001 | Autoimmune Diseases | NA | BeFree | Detail | |
<0.001 | Behcet Syndrome | NA | BeFree | Detail | |
0.004 | Blast Phase | NA | BeFree | Detail | |
0.006 | Blood Platelet Disorders | Whole-exome sequencing confirmation of a novel heterozygous mutation in RUNX1 in... | BeFree | 24853048 | Detail |
0.006 | Blood Platelet Disorders | Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from... | BeFree | 26021490 | Detail |
0.006 | Blood Platelet Disorders | We identified chromosomal deletions within the WASP gene in two patients with Wi... | BeFree | 26175287 | Detail |
<0.001 | Bone neoplasms | NA | BeFree | Detail | |
0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
In patients with acute myeloid leukemia, those with RUNX1 mutations (n=245) had significantly worse ... | CIViC Evidence | Detail |
In non-APL patients with AML (age 18-60), those who had mutations in RUNX1 had significantly shorter... | CIViC Evidence | Detail |
In 878 non-APL patients with AML, those who had mutations in RUNX1 (N=53) had higher rates of refrac... | CIViC Evidence | Detail |
In 878 non-APL patients with AML (18-60 years), those who had mutations in RUNX1 (N=53) had shorter ... | CIViC Evidence | Detail |
In univariate analysis, mutations in RUNX1 were significantly associated with shorter overall surviv... | CIViC Evidence | Detail |
In a study of patients with cytogenically normal acute myeloid leukemia, RUNX1 mutations were more f... | CIViC Evidence | Detail |
NA | DisGeNET | Detail |
Amplification of c-MYC, MLL and RUNX1 genes by means of fluorescence in situ hybridization (FISH) wa... | DisGeNET | Detail |
A recurrent chromosomal abnormality in acute myeloid leukemia is the reciprocal translocation t(8;21... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophagea... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Taken together, our present study indicated that miR-18a increased the permeability of BTB via RUNX1... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transc... | DisGeNET | Detail |
Altogether, RUNX1 dosage could explain the differential phenotype according to RUNX1 mutations, with... | DisGeNET | Detail |
C/EBPα expression is suppressed as a result of common leukemia-associated genetic and epigenetic alt... | DisGeNET | Detail |
Further investigation into the clinical and biological significance of elevated MN1 expression in TE... | DisGeNET | Detail |
RUNX1 and CBFB are among the most frequently mutated genes in human leukemias. | DisGeNET | Detail |
Thus, Wnt/β-catenin signaling induces transcription and translocation of RUNX1 and ETO fusion gene p... | DisGeNET | Detail |
Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic... | DisGeNET | Detail |
Copy number genome alterations are associated with treatment response and outcome in relapsed childh... | DisGeNET | Detail |
We have addressed the issue in the context of TEL-AML1-associated acute lymphoblastic leukemia (ALL)... | DisGeNET | Detail |
Through a novel approach combining gene expression and interactome data analysis, we provide new ins... | DisGeNET | Detail |
Patients with B-other ALL had more relapses (CIR 50%, LFS 41%) than T-ALL and the main precursor-B s... | DisGeNET | Detail |
We reasoned that shared clonal rearrangements of IG or TCR genes by concordant ALL in twins would be... | DisGeNET | Detail |
Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic... | DisGeNET | Detail |
We analyzed cells from peripheral blood and CD34-/CD34+ cells from bone marrow of pediatric acute ly... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;2... | DisGeNET | Detail |
To investigate the physiological function of RUNX1 in human hematopoiesis and pathophysiology of FPD... | DisGeNET | Detail |
Mutations of RUNX1 have been reported to be associated with familial platelet disorder and with a pr... | DisGeNET | Detail |
The RUNX1/ETO (RE) fusion protein, which originates from the t(8;21) chromosomal rearrangement, is o... | DisGeNET | Detail |
RUNX1 translocations and amplifications have been implicated in acute myeloblastic leukemia, acute l... | DisGeNET | Detail |
Here we identify somatic mutations in additional sex combs-like 2 (ASXL2) in 22.7% (25/110) of patie... | DisGeNET | Detail |
ASXL1 mutation, particularly in the context of a coexisting RUNX1 mutation, constitutes a strong adv... | DisGeNET | Detail |
To elucidate the role of epigenetics in RUNX inactivation, we evaluated promoter DNA methylation of ... | DisGeNET | Detail |
In acute myeloid leukaemia (AML), the presence of t(8;21)(q22;q22) and inv(16)(p13q22)/t(16;16)(p13;... | DisGeNET | Detail |
In this study, we present a novel Tet2-dependent leukemia mouse model that closely recapitulates gen... | DisGeNET | Detail |
Because of the pressing need for new therapies in the treatment of acute myleoid leukemia, we invest... | DisGeNET | Detail |
These findings clearly indicate that the RUNX1 mutation is robustly associated with thrombocytopenia... | DisGeNET | Detail |
We identified chromosomal deletions within the WASP gene in two patients with Wiskott-Aldrich syndro... | DisGeNET | Detail |
Amplification of c-MYC, MLL and RUNX1 genes by means of fluorescence in situ hybridization (FISH) wa... | DisGeNET | Detail |
A recurrent chromosomal abnormality in acute myeloid leukemia is the reciprocal translocation t(8;21... | DisGeNET | Detail |
In accordance with our observation that increased expression of miR-126 is associated with unfavorab... | DisGeNET | Detail |
Acute multilineage (B/myeloid) leukemia with RUNX1 duplication/amplification and hypereosinophilia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mutations of RUNX1 have been reported to be associated with familial platelet disorder and with a pr... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we show that Runx1;Runx3 double-knockout (DKO) mice exhibited lethal phenotypes due to bone ma... | DisGeNET | Detail |
In mouse models, class I mutations such as the Bcr-Abl fusion kinase induce MPN by themselves and so... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transc... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Somatic mutation of RUNX1 is implicated in various hematological malignancies, including myelodyspla... | DisGeNET | Detail |
Mutations of RUNX1 have been reported to be associated with familial platelet disorder and with a pr... | DisGeNET | Detail |
Currently, Clinical Laboratory Improvement Amendments-approved testing exists for the following: fam... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We identified chromosomal deletions within the WASP gene in two patients with Wiskott-Aldrich syndro... | DisGeNET | Detail |
Familial platelet disorder (FPD)/AML is an autosomal dominant disorder caused by germline mutation o... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophagea... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Some patients with CIPO carry mutations in RAD21 that disrupt the ability of its product to regulate... | DisGeNET | Detail |
We asked whether minimal residual disease (MRD) determined by RUNX1/RUNX1T1 transcript levels could ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
RUNX1 copy numbers seem to be proportional to the age of B-ALL onset and the frequency of CSF involv... | DisGeNET | Detail |
Moreover, lincRNA-uc002yug.2 promoted a combination of RUNX1 and alternative splicing (AS) factors i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Recent studies also highlight the importance of RUNX1 in solid tumors both as a tumor promoter and a... | DisGeNET | Detail |
In accordance with our observation that increased expression of miR-126 is associated with unfavorab... | DisGeNET | Detail |
The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transformation and was predo... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
These results indicated the significance of RUNX1 for androgen-dependency and that loss of RUNX1 cou... | DisGeNET | Detail |
Disruption of RUNX1 activity has been implicated in the development of hematopoietic neoplasms. | DisGeNET | Detail |
Somatic mutation of RUNX1 is implicated in various hematological malignancies, including myelodyspla... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The aim of our study was 1) to define if the amplification of c-MYC, MLL and RUNX1 genes is related ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
LincRNA-uc002yug.2 involves in alternative splicing of RUNX1 and serves as a predictor for esophagea... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Finally, we discuss how aberrant PTMs of RUNX1 might contribute to tumorigenesis and also strategies... | DisGeNET | Detail |
FPD-iPSCs will be a useful tool to investigate mutant RUNX1-mediated molecular processes in hematopo... | DisGeNET | Detail |
RUNX1 and RUNX3 are frequently associated with leukemias, yet the basis for their involvement in leu... | DisGeNET | Detail |
Our data on increased DSB levels in the BCR-ABL/TEL-AML1 patient's cells support a model where BCR-A... | DisGeNET | Detail |
AML1/ETO cooperates with HIF1α to promote leukemogenesis through DNMT3a transactivation. | DisGeNET | Detail |
We show in this study that both overexpression and knockout of microRNA (miR)-126 surprisingly resul... | DisGeNET | Detail |
Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Mutations in TET2, RUNX1 and JAK2(V617F) are involved in myelodysplastic and/or myeloproliferative s... | DisGeNET | Detail |
AML1 mRNA expression was elevated in patients with PV, essential thrombocythemia, and primary myelof... | DisGeNET | Detail |
These results indicated the significance of RUNX1 for androgen-dependency and that loss of RUNX1 cou... | DisGeNET | Detail |
NA | DisGeNET | Detail |
MiR-302b functions as a tumor suppressor in EOC by targeting RUNX1 and modulating the activity of th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Among five patients diagnosed with MDS/MPN-U, three patients harboured RUNX1 (AML1) mutations; one c... | DisGeNET | Detail |
AML1 mRNA expression was elevated in patients with PV, essential thrombocythemia, and primary myelof... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Acute multilineage (B/myeloid) leukemia with RUNX1 duplication/amplification and hypereosinophilia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Further investigation into the clinical and biological significance of elevated MN1 expression in TE... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we show that Runx1;Runx3 double-knockout (DKO) mice exhibited lethal phenotypes due to bone ma... | DisGeNET | Detail |
In mouse models, class I mutations such as the Bcr-Abl fusion kinase induce MPN by themselves and so... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We report here a multicentre retrospective study of 157 patients treated with AZA for AML/MDS with c... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In accordance with our observation that increased expression of miR-126 is associated with unfavorab... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We identified chromosomal deletions within the WASP gene in two patients with Wiskott-Aldrich syndro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We identified chromosomal deletions within the WASP gene in two patients with Wiskott-Aldrich syndro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Copy number genome alterations are associated with treatment response and outcome in relapsed childh... | DisGeNET | Detail |
We have addressed the issue in the context of TEL-AML1-associated acute lymphoblastic leukemia (ALL)... | DisGeNET | Detail |
Through a novel approach combining gene expression and interactome data analysis, we provide new ins... | DisGeNET | Detail |
We reasoned that shared clonal rearrangements of IG or TCR genes by concordant ALL in twins would be... | DisGeNET | Detail |
Heterogeneity of Abnormal RUNX1 Leading to Clinicopathologic Variations in Childhood B-Lymphoblastic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet d... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Somatic mutation of RUNX1 is implicated in various hematological malignancies, including myelodyspla... | DisGeNET | Detail |
Currently, Clinical Laboratory Improvement Amendments-approved testing exists for the following: fam... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The novelty of this study is dual.On the one hand, miRNAs (e.g. miR-17) can mimic the effects of CBF... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The fourth clonal group (including IDH1 and RUNX1) was acquired at sAML transformation and was predo... | DisGeNET | Detail |
The rs10828317 association was shown to be specifically associated with hyperdiploid ALL, whereas th... | DisGeNET | Detail |
The rs10828317 association was shown to be specifically associated with hyperdiploid ALL, whereas th... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Whole-exome sequencing confirmation of a novel heterozygous mutation in RUNX1 in a pregnant woman wi... | DisGeNET | Detail |
Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet d... | DisGeNET | Detail |
We identified chromosomal deletions within the WASP gene in two patients with Wiskott-Aldrich syndro... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs10828317 dbSNP
- Genome
- hg19
- Position
- chr21:36,160,098-36,421,641
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- MUTATION
- Transcript 1 (CIViC Variant)
- ENST00000300305.3
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/155
- Summary (CIViC Variant)
- RUNX1 mutations are associated with poor prognosis in patients with acute myeloid leukemia or adult T-cell acute lymphocytic leukemia. In younger (<60 years old) AML patients, allogeneic stem cell transplant at complete remission led to much better relapse-free survival than repetitive cycles of high-dose cytarabine.
Genome browser